About Qforce Pharma Consulting LLP
Data last updated:
Qforce Pharma Consulting LLP is a limited liability partnership (LLP) based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 25 October 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAQ-8960. Its GSTIN is 27AAAFQ8420E1ZG (Maharashtra).
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Sambhaji Bhikoba Chawale and Sunanda Sambhaji Chawale.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at Natraj Society S. No. 36/1 Plot 65 Karve Nagar, Pune, Maharashtra, India – 411052.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹2.74 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹54.14 Lakh (net margin 19.8%) and EBITDA of ₹52.45 Lakh (EBITDA margin 19.2%). Revenue has grown at a compounded annual rate (CAGR) of 318% over three years.
The LLP has about 20 employees on its provident fund (EPFO) records.
For more details, the LLP can be reached via its website qforcepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNatraj Society S. No. 36/1 Plot 65 Karve Nagar, Pune, Maharashtra, India – 411052
- IndustryBusiness Outsourcing, Business & IT Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Qforce Pharma Consulting LLP FY 2023 filings available
Qforce Pharma Consulting LLP reported revenue of ₹2.74 Cr (down 23% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Qforce Pharma Consulting LLP
Revenue fell 23% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 318%. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Qforce Pharma Consulting LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹54.14 Lakh | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Qforce Pharma Consulting LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | 19.8% | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Qforce Pharma Consulting are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Qforce Pharma Consulting LLP
Qforce Pharma Consulting has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sambhaji Bhikoba Chawale | Designated Partner | 28 Apr 2024 | 2 Years 5 Months | Current |
| Sunanda Sambhaji Chawale Also directs: Arthsetu Ventures LLP, Lavasa-Temghar Women Farmer Producer Company Limited, Primus Techsystems Private Limited and 2 more | Designated Partner | 28 Apr 2024 | 2 Years 5 Months | Current |
Ownership and Shareholding of Qforce Pharma Consulting LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Qforce Pharma Consulting LLP
Qforce Pharma Consulting LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Qforce Pharma Consulting LLP
Qforce Pharma Consulting LLP has a workforce of 16 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Qforce Pharma Consulting LLP
Qforce Pharma Consulting LLP has 6 designated partner changes on record since 2019: 4 appointments and 2 cessations. The latest: Manisha Shrinivas Inamdar ceased to be Designated Partner on 30 Apr 2024.
Credit Ratings, Litigation & Regulatory Alerts for Qforce Pharma Consulting LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Qforce Pharma Consulting LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Qforce Pharma Consulting LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Qforce Pharma Consulting LLP
Qforce Pharma Consulting has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAAFQ8420E1ZG | Maharashtra | Active | 19 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Qforce Pharma Consulting LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qforce Pharma Consulting LLP
Qforce Pharma Consulting is an active limited liability partnership based in Pune, Maharashtra, India. The LLP works in business and IT consulting, within the business outsourcing industry. It was incorporated on 25 October 2019 (7+ years old) and is registered under LLPIN AAQ-8960.
Qforce Pharma Consulting reported revenue of ₹2.74 Cr for FY 2023 (down 23% YoY).
Qforce Pharma Consulting has 2 current designated partners:
- Sambhaji Bhikoba Chawale - Designated Partner
- Sunanda Sambhaji Chawale - Designated Partner
Qforce Pharma Consulting reported a net profit of ₹54.14 Lakh (net margin 19.8%) and EBITDA of ₹52.45 Lakh (EBITDA margin 19.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Qforce Pharma Consulting is 318% over three years. In the latest year (FY 2023) revenue fell 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Qforce Pharma Consulting is 27AAAFQ8420E1ZG, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Qforce Pharma Consulting is AAQ-8960. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Qforce Pharma Consulting was incorporated on 25 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Manisha Shrinivas Inamdar ceased to be Designated Partner on 30 Apr 2024. Shrinivas Govind Inamdar ceased to be Designated Partner on 30 Apr 2024. Sambhaji Bhikoba Chawale was appointed as Designated Partner on 28 Apr 2024. Qforce Pharma Consulting has 6 designated partner changes on record in total.
Yes, Qforce Pharma Consulting is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).